C&EN: Bachem increasing peptide capacity
In this week's C&EN (by Rick Mullin):
Bachem inks peptide supply pact
Bachem has signed an agreement to supply large volumes of peptides to an undisclosed customer. Manufacturing will primarily take place at the company’s large-scale production facility currently under construction in Bubendorf, Switzerland. The Swiss firm says the order commits it to supplying a volume of peptides valued at over $530 million between 2027 and 2031. The facility at Budendorf, scheduled to open in 2024, will nearly double its manufacturing capacity for peptides and oligonucleotides.
Bold prediction: I'm curious to see if this will increase over the next 1-3 years. I have a real feeling about this...